Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Martial

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
BMC Research Notes|September 10, 2017
Is it a supplementary benefit to use anti-inflammatory agents in the treatment of type 2 diabetes?Nzogang K Patrice, Donkeng J Martial, Telefo P Bruno
Proceedings of the National Academy of Sciences of the United States of America|July 3, 1995
Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactinG D'Angelo, I Struman, J Martial, et al.
Biochemical and Biophysical Research Communications|March 30, 1978
Subunits of yeast RNA polymerase I involved in interactions with DNA and nucleotidesP Valenzuela, P Bull, J Zaldivar, et al.
Archivos De Biologia Y Medicina Experimentales|November 1, 1980
The pH dependence of rat liver RNA polymerases I and IIP Bull, J Martial, R Téllez, et al.
Biochemical and Biophysical Research Communications|June 16, 1975
Inactivation of E. coli RNA polymerase by pyridoxal 5'-phosphate: identificationof a low pKa lysine as the modified residueP Bull, J Zaldivar, A Venegas, et al.
Biochemistry|November 4, 1975
Inactivation of rat liver RNA polymerases I and II and yeast RNA polymerase I by pyrodixal 5'-phosphate. Evidence for the participation of lysyl residues at the active siteJ Martial, J Zaldivar, P Bull, et al.
Endocrinology|September 2, 1998
Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expressionH Lee, I Struman, C Clapp, et al.
Cancer Research|October 5, 2001
Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-/-) miceF Bentzien, I Struman, J F Martini, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1987
Expression of the growth hormone variant gene in human placentaF Frankenne, F Rentier-Delrue, M L Scippo, et al.
Calcified Tissue International|January 1, 1981
Regulation of calcium-binding protein messenger RNA by 1,25-dihydroxycholecalciferolM A Charles, J Martial, D Zolock, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
BMC Research Notes|September 10, 2017
Is it a supplementary benefit to use anti-inflammatory agents in the treatment of type 2 diabetes?Nzogang K Patrice, Donkeng J Martial, Telefo P Bruno
Proceedings of the National Academy of Sciences of the United States of America|July 3, 1995
Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactinG D'Angelo, I Struman, J Martial, et al.
Biochemical and Biophysical Research Communications|March 30, 1978
Subunits of yeast RNA polymerase I involved in interactions with DNA and nucleotidesP Valenzuela, P Bull, J Zaldivar, et al.
Archivos De Biologia Y Medicina Experimentales|November 1, 1980
The pH dependence of rat liver RNA polymerases I and IIP Bull, J Martial, R Téllez, et al.
Biochemical and Biophysical Research Communications|June 16, 1975
Inactivation of E. coli RNA polymerase by pyridoxal 5'-phosphate: identificationof a low pKa lysine as the modified residueP Bull, J Zaldivar, A Venegas, et al.
Biochemistry|November 4, 1975
Inactivation of rat liver RNA polymerases I and II and yeast RNA polymerase I by pyrodixal 5'-phosphate. Evidence for the participation of lysyl residues at the active siteJ Martial, J Zaldivar, P Bull, et al.
Endocrinology|September 2, 1998
Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expressionH Lee, I Struman, C Clapp, et al.
Cancer Research|October 5, 2001
Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-/-) miceF Bentzien, I Struman, J F Martini, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1987
Expression of the growth hormone variant gene in human placentaF Frankenne, F Rentier-Delrue, M L Scippo, et al.
Calcified Tissue International|January 1, 1981
Regulation of calcium-binding protein messenger RNA by 1,25-dihydroxycholecalciferolM A Charles, J Martial, D Zolock, et al.
Pageof 5